A drug delivery system comprising progestogenic compound

PK139982AUndetermined Publication Date: 2009-02-24AKZO NOBEL NV
0 Cites 0 Cited by

Patent Information

Application Number
PK200500265
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-02-24
Patent Text Reader

Abstract

A drug delivery system consisting of one or more compartments and comprising a progestogenic compound dissolved in a thermoplastic polyethylene vinylacetate copolyraer whereby, - if the delivery system consists of one compartment, the compartment comprises (i) a core of a thermoplastic polyethylene vinylacetate copolymer comprising the progestogenic compound, such progestogsnic compound being dissolved in the polyethylene vinylacetate copolymer up to a concentration b&low the saturation level at 25°C, and an estrogenic compound; and (ii) a skin of a thermoplastic polyethylene vinylacetate copolymer covering the core, said skin being permeable for both compounds; - if the delivery system consists of more than one compartment, only one compartment comprises (iii) the progestogenic compound, such progestogenic compound-being dissolved in a core of a thermoplastic polyethylene vinylacetate copolymer up to a concentration below the saturation level at 25°C, and an estrogenic compound; and (iv) a skin of a thermoplastic polyethylene vinylacetate copolymer covering the core, said skin being permeable for both compound.
Need to check novelty before this filing date? Find Prior Art